Recruiting
Phase 3

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

Sponsor:

Ansun Biopharma, Inc.

Code:

NCT03808922

Conditions

Lower Respiratory Tract Infection

Parainfluenza

Immunocompromised

COVID-19

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

DAS181

Placebo

DAS181 COVID-19

DAS181 OL

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information